dementia with lewy bodies news - Search News

CervoMed, Dementia

Benzinga.com · 2d

CervoMed's Dementia Candidate Fails In Mid-Stage Study, Stock Plummets

CervoMed reports RewinD-LB trial results for neflamapimod in dementia with Lewy bodies, highlighting missed endpoints and upcoming data timelines.

CervoMed's dementia drug fails mid-stage trial, shares slump

CervoMed said on Tuesday its experimental drug for a common degenerative brain disease did not meet the main or secondary goals in a mid-stage clinical trial, sending the U.S. drug developer shares down 77% in early trading.

Business Insider · 2d

CervoMed: Neflamapimod Phase 2b Trial In Dementia With Lewy Bodies Patients Fails To Meet Targets

CervoMed Inc. (CRVO) announced Tuesday that its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with dementia

Cervomed analyzing data after phase IIb miss in Lewy body dementia

Cervomed Inc. executives said they intend to scrutinize low plasma drug concentrations that appeared to spoil results from the phase IIb Rewind-LB trial testing neflamapimod in patients with dementia with Lewy bodies.

2d

CervoMed’s stock craters 77% after failed trial of treatment for rare brain disease

CervoMed Inc.’s stock cratered early Tuesday after the biotech company said a midstage trial of a treatment for patients with ...

7h

CervoMed price target lowered to $4 from $45 at Roth MKM

Roth MKM lowered the firm’s price target on CervoMed (CRVO) to $4 from $45 and keeps a Buy rating on the shares. The company ...

2d

CervoMed Announces Topline Data from RewinD-LB Phase 2b Clinical Trial in Patients with Dementia with Lewy Bodies

Neflamapimod did not demonstrate statistically significant effects versus placebo on primary and secondary endpoints at 16 weeks——Favorable ...

Wigan Today on MSN20d

Wigan charity celebrates five years of funding UK’s first Consultant Admiral Nurse for Lewy body dementia

Dementia charity Lewy Body Society is celebrating its five years of funding the UK’s first Consultant Admiral Nurse for Lewy ...

Medical Xpress on MSN16d

New biomarkers could improve diagnosis and tracking of Parkinson's disease and Lewy body dementia

"Currently, the field has been using clinically defined diagnostic criteria of Parkinson's disease or dementia with Lewy ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results